Biomarker Assays CROs in United States
27 published
27 published CROs match Biomarker Assays in United States.
Locations in this set include United States, China, United Kingdom, Australia, India, and Germany.
Capabilities that show up most often in this set: Biologics (Monoclonal Antibodies), Biologics (Other), Small Molecule, Cell Therapy, and Antibody-Drug Conjugate (ADC).
Matching companies
QPSQPS provides integrated contract research and clinical services spanning bioanalysis, preclinical development, and early-to-late phase clinical trials across multiple therapeutic areas including oncology, dermatology, and women's health.
Reaction BiologyGlobal preclinical CRO specializing in kinase drug discovery, cell-based assays, in vivo pharmacology, and immuno-oncology with 1,000+ cell lines and hundreds of validated protein targets across US and EU facilities.
ResolianGlobal bioanalytical, biomarker, and analytical sciences CRO with labs across four continents supporting all phases of drug development.
SoCal Biosciences, Inc.San Diego-based bioanalytical CRO specializing in assay development and analysis for mRNA, oligonucleotides, and large molecules across discovery through clinical development phases.
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
TRiCBIOTRiCBIO provides human organoid research services for efficacy, safety, mechanism and immune-context studies using PDO 2.0 and ALI platforms, supporting biopharma and CRO teams in candidate evaluation and translational research.
iFyber, LLCPreclinical CRO providing custom method development, antimicrobial efficacy and biofilm testing, LC-MS/MS analysis, and in vitro biocompatibility studies for R&D teams. Work spans biology, chemistry, and materials science.
Markdown mirror: /services/biomarker-assays/us.md